Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine

Clinical trial NCT06184542 · RECRUITING

Trial details

NCT number: NCT06184542
Sponsor: Institute of Medical Biology, Chinese Academy of Medical Sciences
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Diphtheria Tetanus Pertussis

Start date: 2023-12-23
Primary completion: 2024-12-15
Enrollment: 460

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.